186 related articles for article (PubMed ID: 22673088)
1. Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein.
Shimojima M; Kawaoka Y
J Vet Med Sci; 2012 Oct; 74(10):1363-6. PubMed ID: 22673088
[TBL] [Abstract][Full Text] [Related]
2. Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan.
Fedeli C; Torriani G; Galan-Navarro C; Moraz ML; Moreno H; Gerold G; Kunz S
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237830
[TBL] [Abstract][Full Text] [Related]
3. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.
Beyer WR; Westphal M; Ostertag W; von Laer D
J Virol; 2002 Feb; 76(3):1488-95. PubMed ID: 11773421
[TBL] [Abstract][Full Text] [Related]
4. Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry.
Shimojima M; Ströher U; Ebihara H; Feldmann H; Kawaoka Y
J Virol; 2012 Feb; 86(4):2067-78. PubMed ID: 22156524
[TBL] [Abstract][Full Text] [Related]
5. Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins.
Miletic H; Fischer YH; Neumann H; Hans V; Stenzel W; Giroglou T; Hermann M; Deckert M; Von Laer D
Hum Gene Ther; 2004 Nov; 15(11):1091-100. PubMed ID: 15610609
[TBL] [Abstract][Full Text] [Related]
6. O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.
Imperiali M; Thoma C; Pavoni E; Brancaccio A; Callewaert N; Oxenius A
J Virol; 2005 Nov; 79(22):14297-308. PubMed ID: 16254364
[TBL] [Abstract][Full Text] [Related]
7. Is the TAM receptor Axl a receptor for lymphocytic choriomeningitis virus?
Sullivan BM; Welch MJ; Lemke G; Oldstone MB
J Virol; 2013 Apr; 87(7):4071-4. PubMed ID: 23325690
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice.
Lee J; Hashimoto M; Im SJ; Araki K; Jin HT; Davis CW; Konieczny BT; Spies GA; McElrath MJ; Ahmed R
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003483
[TBL] [Abstract][Full Text] [Related]
9. TNFRs and Control of Chronic LCMV Infection: Implications for Therapy.
Clouthier DL; Watts TH
Trends Immunol; 2015 Nov; 36(11):697-708. PubMed ID: 26481667
[TBL] [Abstract][Full Text] [Related]
10. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
Takenaga T; Zhang Z; Muramoto Y; Fehling SK; Hirabayashi A; Takamatsu Y; Kajikawa J; Miyamoto S; Nakano M; Urata S; Groseth A; Strecker T; Noda T
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578344
[TBL] [Abstract][Full Text] [Related]
11. Gammaherpesvirus latency differentially impacts the generation of primary versus secondary memory CD8+ T cells during subsequent infection.
Barton ES; Rajkarnikar S; Langston PK; Price MJ; Grayson JM
J Virol; 2014 Nov; 88(21):12740-51. PubMed ID: 25142586
[TBL] [Abstract][Full Text] [Related]
12. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
13. Receptor use by pathogenic arenaviruses.
Reignier T; Oldenburg J; Noble B; Lamb E; Romanowski V; Buchmeier MJ; Cannon PM
Virology; 2006 Sep; 353(1):111-20. PubMed ID: 16797051
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytic choriomeningitis arenavirus requires cellular COPI and AP-4 complexes for efficient virion production.
Byford O; Shaw AB; Tse HN; Todd EJAA; Álvarez-Rodríguez B; Hewson R; Fontana J; Barr JN
J Virol; 2024 Mar; 98(3):e0200623. PubMed ID: 38334330
[TBL] [Abstract][Full Text] [Related]
15. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).
Ruiz-Jarabo CM; Ly C; Domingo E; de la Torre JC
Virology; 2003 Mar; 308(1):37-47. PubMed ID: 12706088
[TBL] [Abstract][Full Text] [Related]
16. RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus.
Sánchez AB; Perez M; Cornu T; de la Torre JC
J Virol; 2005 Sep; 79(17):11071-81. PubMed ID: 16103158
[TBL] [Abstract][Full Text] [Related]
17. Differential Inhibition of Macrophage Activation by Lymphocytic Choriomeningitis Virus and Pichinde Virus Is Mediated by the Z Protein N-Terminal Domain.
Xing J; Chai Z; Ly H; Liang Y
J Virol; 2015 Dec; 89(24):12513-7. PubMed ID: 26423945
[TBL] [Abstract][Full Text] [Related]
18. Role of DC-SIGN in Lassa virus entry into human dendritic cells.
Goncalves AR; Moraz ML; Pasquato A; Helenius A; Lozach PY; Kunz S
J Virol; 2013 Nov; 87(21):11504-15. PubMed ID: 23966408
[TBL] [Abstract][Full Text] [Related]
19. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
[TBL] [Abstract][Full Text] [Related]
20. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus.
Cao W; Henry MD; Borrow P; Yamada H; Elder JH; Ravkov EV; Nichol ST; Compans RW; Campbell KP; Oldstone MB
Science; 1998 Dec; 282(5396):2079-81. PubMed ID: 9851928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
